Aspen aerogels inc (ASPN)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13Jun'13
Revenue:
Total revenue

139,882

139,375

128,549

117,061

109,199

104,361

95,880

97,012

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product

-

-

-

-

-

-

-

-

-

-

-

-

105,530

-

124,926

126,975

129,607

120,532

111,176

104,839

100,977

99,259

92,808

90,020

0

0

0

Research services

-

-

-

-

-

-

-

-

-

-

-

-

2,389

-

2,556

2,486

2,232

1,986

1,943

2,178

2,559

3,140

3,487

3,816

0

0

0

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

107,919

-

127,482

129,461

131,839

122,518

113,119

107,017

103,536

102,399

96,295

93,836

0

0

0

Cost of revenue:
Product

-

-

-

-

-

-

-

-

-

-

-

-

87,601

-

96,694

99,921

104,012

96,865

92,036

85,945

83,981

83,677

79,086

78,036

0

0

0

Research services

-

-

-

-

-

-

-

-

-

-

-

-

1,313

-

1,353

1,335

1,166

1,005

1,051

1,140

1,307

1,642

1,786

1,918

0

0

0

Gross profit

28,546

26,284

20,560

14,347

13,577

12,669

14,891

18,310

19,260

18,671

14,592

16,046

19,005

23,311

29,435

28,205

26,661

24,648

20,032

19,932

18,248

17,080

15,423

13,882

0

0

0

Operating expenses:
Research and development

8,706

8,407

7,534

6,872

6,642

6,319

6,054

6,138

6,209

6,180

6,135

5,995

5,572

5,306

5,176

4,994

5,259

5,253

5,519

5,631

6,000

5,980

5,849

5,769

0

0

0

Sales and marketing

15,370

15,557

14,525

13,594

13,806

13,794

13,614

13,298

12,993

12,604

12,142

12,453

11,858

11,810

11,654

11,391

11,292

10,562

10,266

9,686

10,384

10,290

10,376

10,602

0

0

0

General and administrative

15,754

16,479

18,416

18,012

18,900

19,116

16,818

17,130

16,892

19,023

19,540

20,197

20,089

17,415

16,431

15,718

15,358

15,068

14,825

15,082

17,754

16,853

17,247

15,833

0

0

0

Total operating expenses

39,830

40,443

47,831

45,834

46,704

46,585

36,486

36,566

36,094

37,807

37,817

38,645

37,519

34,531

33,261

32,103

31,909

30,883

30,610

30,399

34,138

33,123

33,472

32,204

0

0

0

Loss from operations

-11,284

-14,159

-27,271

-31,487

-33,127

-33,916

-21,595

-18,256

-16,834

-19,136

-23,225

-22,599

-18,514

-11,220

-3,826

-3,898

-5,248

-6,235

-10,578

-10,467

-15,890

-16,043

-18,049

-18,322

0

0

0

Interest expense, net

-448

-406

-446

-473

-473

-524

-420

-315

-251

-185

-155

-134

-134

-147

-161

-170

-176

-182

-192

-193

-34,175

-50,281

0

0

0

-

-

Postponed financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Loss on exchange of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Costs associated with postponed public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total interest expense, net

-448

-406

-446

-473

-473

-524

-420

-315

-251

-185

-155

-790

-790

-803

-817

-170

-176

-182

-192

-193

-34,175

-50,281

-58,263

-74,562

0

0

0

Net loss

-11,732

-14,565

-27,717

-31,960

-33,600

-34,440

-22,015

-18,571

-17,085

-19,321

-23,380

-23,389

-19,304

-12,023

-4,643

-4,068

-5,424

-6,417

-10,770

-10,660

-50,065

-66,324

-76,312

-92,884

0

0

0

Net income (loss) attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-76,312

-92,884

0

0

0

Net loss per share:
Basic and diluted

-0.13

-0.04

-0.09

-0.22

-0.25

-0.60

-0.27

-0.29

-0.29

-0.08

-0.13

-0.23

-0.39

-0.25

-0.13

-0.06

-0.08

-

-

-

-

-

-

-

-

-

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.11

-0.12

-0.12

-

-0.10

-13.88

-6,066.56

-4,049.41

-6,051.64

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.11

-0.12

-0.12

-

-0.10

-13.88

-6,066.56

-4,049.41

-6,051.64

Weighted-average common shares outstanding:
Basic and diluted

25,194

24,176

24,171

24,118

23,930

23,836

23,808

23,743

23,567

23,491

23,442

23,369

23,257

23,216

23,168

23,111

23,063

22,895

23,060

22,999

22,992

23,361

22,997

3,035

3

-

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

3

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

3

Product [Member]
Total revenue

138,456

136,934

125,884

114,180

106,387

102,123

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenue

110,680

111,759

106,510

101,154

94,115

90,660

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research Services [Member]
Total revenue

1,426

2,441

2,665

2,881

2,812

2,238

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenue

656

1,332

1,479

1,560

1,507

1,032

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-